Key result
Recent Cryo-EM structural studies of the TMEM16A channel reveal the molecular basis and mechanism of its gating and permeation, providing a foundation for future drug development.
Why the study?
A thorough understanding of the structural characteristics of TMEM16A is important to reveal its physiological and pathological roles and develop targeted drugs.
Understanding the structural basis of TMEM16A gating and permeation provides an important foundation for developing targeted drugs for diseases like hypertension and cystic fibrosis.
May inform TMEM16A-targeted therapies for hypertension and cystic fibrosis; leaves open clinical translation.
The calcium-activated chloride channel, also known as TMEM16A, shows both calcium and membrane potential dependent activation. The channel is expressed broadly and contributes to a variety of physiological processes, and it is expected to be a target for the treatment of diseases such as hypertension, pain, cystic fibrosis and lung cancer. A thorough understanding of the structural characteristics of TMEM16A is important to reveal its physiological and pathological roles. Recent studies have released several Cryo-EM structures of the channel, revealed the structural basis and mechanism of the gating of the channel. This review focused on the understandings of the structural basis and molecular mechanism of the gating and permeation of TMEM16A channel, which will provide important basis for the development of drugs targeting TMEM16A.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2020) conducted a review in TMEM16A channel structure and function. TMEM16A channel structural studies was evaluated. Recent Cryo-EM structural studies of the TMEM16A channel reveal the molecular basis and mechanism of its gating and permeation, providing a foundation for future drug development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: